Skip to main content

Peer Review reports

From: Optimized anti-tuberculosis duration for drug-susceptible pulmonary tuberculosis-diabetes mellitus comorbidities: study protocol for a multicenter randomized controlled trial

Original Submission
8 Aug 2024 Submitted Original manuscript
3 Sep 2024 Author responded Author comments - Guofang Deng
Resubmission - Version 2
3 Sep 2024 Submitted Manuscript version 2
Publishing
4 Sep 2024 Editorially accepted
27 Sep 2024 Article published 10.1186/s12890-024-03271-8

You can find further information about peer review here.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us